STEPHANIE BURNS: Open Payments
NPI 1578865069 · GREENWOOD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,772 in 114 payments from 20 companies in 2025. Trend: 2023 $1,676 · 2024 $2,122 · 2025 $1,772
Food & beverage: $1,772
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $357 |
| UCB, Inc. | 11 | $229 |
| Regeneron Healthcare Solutions, Inc. | 15 | $216 |
| Galderma Laboratories, L.P. | 7 | $156 |
| Amgen Inc. | 8 | $140 |
| Novartis Pharmaceuticals Corporation | 6 | $96 |
| E.R. Squibb & Sons, L.L.C. | 4 | $79 |
| Almirall LLC | 3 | $78 |
| GENZYME CORPORATION | 4 | $70 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $57 |
Products named: Bimzelx, DUPIXENT, SKYRIZI, NEMLUVIO, RINVOQ, Otezla, Sotyktu, LIBTAYO.
Industry payments across IN — which companies pay providers there.
